Clinical Trial Update: Anlotinib Combined With Benmelstobart for Advanced Pheochromocytoma [Phase 2]

View source ↗

Summary

Phase 2 study of anlotinib combined with Benmelstobart for advanced pheochromocytoma; the trial status is not yet recruiting, sponsored by Sun Yat-sen Universit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pheochromocytoma

Drugs mentioned

• Anlotinib (anlotinib)
• Benmelstobart

Snippet

Sponsor: Sun Yat-sen University | Conditions: Pheochromocytoma | Phase 2 | Status: NOT_YET_RECRUITING